GALLIUM GA-68 GOZETOTIDE
GALLIUM GA-68 GOZETOTIDE is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Gallium Ga-68 PSMA-11. Available dosage form: injection, solution.
Drug Details
- Generic Name
- GALLIUM GA-68 GOZETOTIDE
- Brand Names
- Gallium Ga-68 PSMA-11
- Application Number
- NDA212642
- Sponsor
- UCLA Biomedical Cyclotron
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- GALLIUM GA-68 GOZETOTIDE
Indications and Usage
1 INDICATIONS AND USAGE Gallium Ga 68 gozeotide injection is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. Gallium Ga 68 gozetotide injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. ( 1 )